Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
Odyssey Health, Inc., a medical device company based in Las Vegas, Nevada, announced on Monday an extension to the maturity dates of promissory notes with certain company directors and officers. The amendments, affecting notes originally issued on December 21 and 22, 2021, and subsequently amended on various dates through July 31, 2024, now extend the maturity date to July 31, 2025.
The promissory notes in question were held by two directors and two officers of the company. Despite the extension of the maturity date, all other terms and conditions of the notes remain unchanged. This decision was formalized on January 31, 2025, and the details were filed with the Securities and Exchange Commission (SEC) in an 8-K filing on February 6, 2025.
Odyssey Health, Inc., previously known as Odyssey Group International, Inc., is incorporated in Nevada and operates within the surgical and medical instruments and apparatus sector under the SIC code 3841. The company’s common stock is traded on the OTC market under the ticker symbol ODYY.
The financial implications of this extension are not disclosed in the filing, but such amendments are often undertaken for various strategic financial management reasons, such as to provide the company with more time to meet its financial obligations or to renegotiate the terms of its debts.
Investors and interested parties can refer to the Form of Amendment No. 10 to Promissory Note, which is attached as Exhibit 10.1 to the 8-K filing, for more detailed information. This filing is part of the company’s ongoing reporting obligations under the Securities Exchange Act of 1934.
This news is based on a press release statement and provides a factual update on the company’s financial arrangements without offering an opinion on the company’s financial position or future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.